Allergan (NYSE:AGN) and CRISPR company, Editas Medicine Inc. (NASDAQ:EDIT), announce strategic deal to focus on eye diseases
Allergan Inc. (NASDAQ:AGN) and Editas Medicine Inc. (NASDAQ:EDIT) have announced the execution of an exclusive licensing transaction in which Allergan receives an option on up… Read More »Allergan (NYSE:AGN) and CRISPR company, Editas Medicine Inc. (NASDAQ:EDIT), announce strategic deal to focus on eye diseases